5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes : : comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
issn: 1860-8973
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2019
- Urheber
- DOI
-
10.1007/s11419-018-0451-8
- URN
-
urn:nbn:de:bsz:25-freidok-175006
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Entstanden
- 2019
Ähnliche Objekte (12)
Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE
Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE
5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA
Death after smoking of fentanyl, 5F-ADB, 5F-MDMB-P7AICA and other synthetic cannabinoids with a bucket bong
Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE
Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE
Impact of legislation on NPS markets in Germany – the rise and fall of 5F‐ADB
Fettsäureethylester als Marker exzessiven Alkoholkonsums : analytische Bestimmung im Haar und in der Hautoberflächenlipiden mittels Headspace-Festphasenmikroextraktion und Gaschromatographie-Massenspektrometrie
Detection and phase I metabolism of the 7‐azaindole‐derived synthetic cannabinoid 5F‐AB‐P7AICA including a preliminary pharmacokinetic evaluation
Human phase‐I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F‐EDMB‐PICA and EDMB‐PINACA
Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine - potential impact on therapeutic decisions
Haus Heiligengrabstraße 5f
Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE
Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE
5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA
Death after smoking of fentanyl, 5F-ADB, 5F-MDMB-P7AICA and other synthetic cannabinoids with a bucket bong
Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE
Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE
Impact of legislation on NPS markets in Germany – the rise and fall of 5F‐ADB
Fettsäureethylester als Marker exzessiven Alkoholkonsums : analytische Bestimmung im Haar und in der Hautoberflächenlipiden mittels Headspace-Festphasenmikroextraktion und Gaschromatographie-Massenspektrometrie
Detection and phase I metabolism of the 7‐azaindole‐derived synthetic cannabinoid 5F‐AB‐P7AICA including a preliminary pharmacokinetic evaluation
Human phase‐I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F‐EDMB‐PICA and EDMB‐PINACA
Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine - potential impact on therapeutic decisions
Haus Heiligengrabstraße 5f
Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE
Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE
5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA
Death after smoking of fentanyl, 5F-ADB, 5F-MDMB-P7AICA and other synthetic cannabinoids with a bucket bong
Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE
Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE
Impact of legislation on NPS markets in Germany – the rise and fall of 5F‐ADB
Fettsäureethylester als Marker exzessiven Alkoholkonsums : analytische Bestimmung im Haar und in der Hautoberflächenlipiden mittels Headspace-Festphasenmikroextraktion und Gaschromatographie-Massenspektrometrie
Detection and phase I metabolism of the 7‐azaindole‐derived synthetic cannabinoid 5F‐AB‐P7AICA including a preliminary pharmacokinetic evaluation
Human phase‐I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F‐EDMB‐PICA and EDMB‐PINACA
Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine - potential impact on therapeutic decisions